The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...

CurePSP awarded CARES grants for multi-center projects aimed at improving care, access, and education for patients with PSP, ...

Advancing Light Therapy Research to Enhance Quality of Life for Parkinson's Patients This trial is important becau ...

The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

With thousands of press releases published each month, it can be difficult to keep up with everything on . To help healthcare ...

Back in 2021, a 46-year-old woman with severe heart failure was given a lab-made patch made up of 800 million cells derived ...

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

Rainwater Prizes honor researchers worldwide who are advancing discoveries for diseases caused by tau protein accumulations ...

The world-renowned Israeli-Argentine pianist and conductor Daniel Barenboim revealed Thursday he is suffering from ...

A gold-standard University College of London study found a type of weight-loss jab had no benefit in alleviating a condition ...